Tongrentang mercury over standard time-honored brand also damage health?
[Beijing Direct News Network May 7th] (Dimension female beauty channel)Tongrentang, a time-honored brand of traditional Chinese medicine, has recently fallen into the storm of "quality gate". On May 7, the Hong Kong Department of Health announced on its official website that a group of Tongrentang "jianti wubu pills" had been found to contain about five times more mercury (mercury) than the upper limit standard, and had ordered product dealers to recycle it. As the incident involves Beijing Tongrentang, a famous traditional Chinese medicine enterprise, and its new share, Tongrentang Guoyao, has just been listed in Hong Kong, it has attracted the attention of the media and the public. In response, the Securities Department of Tongrentang technology said that the batch of products does not belong to Tongrentang technology, and the company is investigating the source of products. Tongrentang mercury over standard time-honored brand also damage health?
Beyond the standard! Tongrentang one product is forcibly recycled
According to the Hong Kong Department of health, the Chinese patent medicines that are required to be recycled are "Tongrentang jianti wubu pills" produced by Beijing Tongrentang Hong Kong Pharmaceutical Management Co., Ltd., a licensed Chinese patent medicine wholesaler, with the registration number of hkp-08760. Because the mercury content of the batch was found to exceed the upper limit standard, the samples tested by the government exceeded the limit by 5 times. According to the preliminary investigation, the above-mentioned Chinese patent medicines are manufactured in the mainland and imported to Hong Kong for sale through Tongrentang. The Chinese patent medicine is used to regulate the body of adults, but its ingredients should not contain mercury. Tongrentang mercury over standard time-honored brand also damage health?
It is understood that acute mercury poisoning can cause inflammation of the mouth, long-term ingestion of Mercury will cause damage to the nervous system and kidney. The Hong Kong Department of Health said it had not received any reports of discomfort after taking the Chinese patent medicine, but the investigation was still in progress and called on the public to immediately stop using the Chinese patent medicine.
At the end of last year, the State Pharmacopoeia Committee, based on the 2010 edition of the Chinese Pharmacopoeia, issued the draft standards for the limited amount of heavy metals, agricultural residues, aflatoxins and other substances in traditional Chinese medicine, with the deadline for publication being April 24 this year.
According to the draft and the appendix of the Chinese Pharmacopoeia, "Mercury in Chinese herbal medicines other than minerals, animals and marine medicines shall not exceed 1mg / kg."
In addition, it is worth mentioning that on May 7, the stock price of Tongrentang Guoyao (08138. HK), which was split by Tongrentang technology, soared 114.8% on the first day of listing on the Hong Kong Growth Enterprise Market, setting a "good start" and closing at HK $6.53. Its main business includes Tongrentang "Wangyao" Angong Niuhuang and other products, and its market prospect is widely optimistic. On May 8, Tongrentang Guoyao was not affected by negative factors in the A-share market and continued to maintain its strength.